SCHEMBL7418848

SCHEMBL7418848

OCc1ccc2oc(-c3c(Cl)cccc3Cl)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.57
ITGA4 P13612 3/20 0.57
ITGB7 P26010 3/20 0.57
SMN1; SMN2 Q16637 6/20 0.45
MAPT P10636 5/20 0.45
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
TP53 P04637 4/20 0.45
KDM4E B2RXH2 3/20 0.45
MEN1 O00255 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
KMT2A Q03164 3/20 0.45
HSD17B10 Q99714 3/20 0.45
ALOX15 P16050 1/20 0.45
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
PDE10A Q9Y233 1/20 0.43
TSHR P16473 1/20 0.43
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873451 0.86 ITGB1 (0.55) ITGB1ITGA4ITGB7SMN1; SMN2MAPT
SCHEMBL7420912 0.79 ITGB1 (0.68) ITGB1ITGA4ITGB7SMN1; SMN2MAPT
SCHEMBL7420913 0.79 ITGB1 (0.68) ITGB1ITGA4ITGB7SMN1; SMN2MAPT
SCHEMBL14338225 0.78 SMN1; SMN2 (0.60) SMN1; SMN2MAPTNPC1RAB9ATP53
SCHEMBL6614228 0.76 HPSE (0.55) ITGB1ITGA4ITGB7KDM4E
SCHEMBL444748 0.76 HDAC6 (0.55) ITGB1ITGA4ITGB7SMN1; SMN2MAPT
SCHEMBL26686764 0.75 NPC1 (0.64) SMN1; SMN2MAPTNPC1RAB9ATP53
SCHEMBL5638541 0.75 MAPT (0.54) SMN1; SMN2MAPTNPC1RAB9ATP53
SCHEMBL9508846 0.75 NPC1 (0.51) SMN1; SMN2MAPTNPC1RAB9ATP53
SCHEMBL12704798 0.74 SMN1; SMN2 (0.45) ITGB1ITGA4ITGB7SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed